Results 101 to 110 of about 14,308 (181)

Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfa. [PDF]

Blood Adv
Kalmer M, Grasshoff M, Maié T, Pannen K, Toledo MAS, Vieri M, Olschok K, Lemanzyk R, Lazarevic J, Junge B, Baumeister J, Galauner A, Chapal Ilani N, Bar D, Colin E, Cheng M, Schifflers J, Kricheldorf K, Schemionek M, Brümmendorf TH, Weiskirchen R, Shlush L, Zenke M, Chatain N, Costa IG, Koschmieder S.   +25 more
europepmc   +1 more source

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma. [PDF]

Clin Cancer Res, 2021
Najjar YG, McCurry D, Lin H, Lin Y, Zang Y, Davar D, Karunamurthy A, Drabick JJ, Neves RI, Butterfield LH, Ernstoff MS, Puzanov I, Skitzki JJ, Bordeaux J, Summit IB, Bender JO, Kim JY, Chen B, Sarikonda G, Pahuja A, Tsau J, Alfonso Z, Laing C, Pingpank JF, Holtzman MP, Sander C, Rose A, Zarour HM, Kirkwood JM, Tarhini AA.   +29 more
europepmc   +1 more source

Incidence and predictors of HBsAg loss following addition of pegylated interferon Alfa-2b in chronic hepatitis B patients suppressed by nucleos(t)ide analogues: a multicenter, prospective, cohort study. [PDF]

Virol J
Zhao J, Bian D, Xie D, Lv J, Lin L, Chen X, Zhang L, Feng B, Xu X, Lu F, Zheng S.   +10 more
europepmc   +1 more source

Autoanticuerpos en pacientes hematológicos tratados con interferón alfa

Revista Cubana de Hematología, Inmunología y Hemoterapia
Se estudió la presencia de autoanticuerpos en 45 pacientes con enfermedades hematológicas: 32 con leucemia mieloide crónica (LMC) y 13 con otras enfermedades linfoproliferativas (ELP).
Antonio A Bencomo Hernández, María E Alfonso Valdés, Arturo Munster Infante, Paulino Basanta Otero, Edgardo Espinosa Martínez, Porfirio Hernández Ramírez   +5 more
doaj  

Investigation into the pharmacodynamics and pharmacokinetics of recombinant human interferon alfa-2b vaginal suppository following process optimization in chinese rhesus macaque. [PDF]

Sci Rep
Zhang X, Zhou B, Gong Y, Liu Y.
europepmc   +1 more source

Organizing pneumonia in a patient following treatment of chronic hepatitis B with pegylated interferon alfa-2b: A case report. [PDF]

IDCases
Tian B, Wang P, Shan C, Gao C, Zhang Q.
europepmc   +1 more source

Treatment of thrombocytopenia with alfa interferon. [PDF]

BMJ, 1987
A M, Lever, M G, Brook, I, Yap, H C, Thomas   +3 more
openaire   +2 more sources

DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera. [PDF]

Blood
Abu-Zeinah G, Erdos K, Lee N, Ganom Y, Klade C, Krejcy K, Gisslinger H, Silver RT, Scandura JM.   +8 more
europepmc   +1 more source

Combination therapy with ruxolitinib and pegylated interferon alfa-2a in newly diagnosed patients with polycythemia vera. [PDF]

Blood Adv
Sørensen AL, Skov V, Kjær L, Bjørn ME, Eickhardt-Dalbøge CS, Larsen MK, Nielsen CH, Thomsen C, Rahbek Gjerdrum LM, Knudsen TA, Ellervik C, Overgaard UM, Andersen CL, Hasselbalch H.   +13 more
europepmc   +1 more source

Diabetes mellitus tipo 1 en una paciente con hepatitis c durante el tratamiento con interferón alfa. Primer caso comunicado en Cuba

Revista Cubana de Hematología, Inmunología y Hemoterapia
El Interferón alfa (IFN-alfa), se utiliza junto a otros antivirales en el tratamiento de la hepatitis C crónica. Se han descrito alteraciones autoinmunes durante su uso, destacándose las enfermedades del tiroides y la diabetes mellitas tipo 1 (DM 1 ...
Catalino R Ustariz García
doaj